Persistent activation of the NF-κB pathway in the liver leads to a chronic inflammatory state and to insulin resistance, that further promote the development of NAFLD and NASH (81, 254). The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.